Features | Partner Sites | Information | LinkXpress
Sign In


Cancer Immunotherapy Sector Predicted to Surge to USD 9 Billion Across Major Pharma Through 2022

The immunotherapy market will experience substantial growth through 2022, increasing from USD 1.1 billion in 2012 to nearly USD 9 billion in 2022 in the United Kingdom, United States, France, Germany, Italy, Spain, and Japan, according to recent market research.   More...
30 Jul 2014

Abbott Selling Developed Market Generics Portfolio

Abbott Laboratories has sold its developed market generic drugs business to Mylan in a deal worth USD 5.3 billion.  More...
29 Jul 2014

IDT Acquires SURVEYOR Nuclease Product Line from Transgenomic

The SURVEYOR line is to be used by Integrated DNA Technologies primarily to support researchers performing mutation detection and potentially-clinical genome editing, and by Transgenomic primarily to support diagnostic and other clinical applications.  More...
13 Jul 2014

A Surge in IPOs Revitalize Investments for the Global Pharma and Biotech

Anti-infective drugs, oncology, and pharmaceutical contract laboratories attract the most investment up to now.   More...
16 Jun 2014

Teva Pharmaceuticals to Acquire Labrys Biologics

Teva Pharmaceutical Industries will acquire Labrys Biologics. The acquisition will broaden Teva’s array of biotechnology assets and capabilities.  More...
15 Jun 2014

Metabolon Collaborates with GSK for Metabolomics Research Platform

Metabolon, a diagnostics and research services company offering metabolomics research platforms, has entered into a collaboration with GlaxoSmithKline to provide metabolomic profiling services and to collaborate on other research projects utilizing Metabolon’s DiscoveryHD4 platform.  More...
02 Jun 2014

European Bioinformatics Sector Expected to Surge

An intra-European purchase agreement will boost the bioinformatics field by combining an exhaustive genomics data base with a highly intuitive software suite.   More...
01 Jun 2014

BioResearch Industry News channel updates the reader on mergers and takeovers, on cooperative agreements and on trends in the biotech industry worldwide.
Copyright © 2000-2014 Globetech Media. All rights reserved.